| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 1150-41-0 | Guanidine,N-(1-methylbenzo[f]quinazolin-3-yl)-, hydrochloride (1:1); Guanidine,(1-methylbenzo[f]quinazolin-3-yl)-, monohydrochloride (8CI,9CI); Benzo[f]quinazoline,guanidine deriv. |  | C14H14ClN5 | 詳情 | 供應商 | |
| 134867-97-3 | Hydrazinecarboximidamide,2-[(2-amino-5-chlorophenyl)phenylmethylene]-, (Z)- (9CI) |  | C14H14ClN5 | 詳情 | 供應商 | |
| 134867-99-5 | Hydrazinecarboximidamide,2-[(2-amino-5-chlorophenyl)phenylmethylene]-, (E)- (9CI); 2-amino-5-chlorobenzophenoneamidinohydrazone |  | C14H14ClN5 | 詳情 | 供應商 | |
| 6958-86-7 | 1H-Pyrazolo[3,4-d]pyrimidin-4-amine,6-chloro-1-methyl-N-(2-phenylethyl)-; 1H-Pyrazolo[3,4-d]pyrimidine,6-chloro-1-methyl-4-(phenethylamino)- (8CI); NSC 19139 |  | C14H14ClN5 | 詳情 | 供應商 | |
| 5413-97-8 | 1H-Pyrazolo[3,4-d]pyrimidin-4-amine,6-chloro-N-(2,4-dimethylphenyl)-1-methyl-; 1H-Pyrazolo[3,4-d]pyrimidine,6-chloro-1-methyl-4-(2,4-xylidino)- (6CI,8CI); NSC 7872 |  | C14H14ClN5 | 詳情 | 供應商 | |
| 444731-75-3 | N-(2-氯嘧啶-4-基)-N-甲基-2,3-二甲基-2H-吲唑-6-胺 | 2H-Indazol-6-amine,N-(2-chloro-4-pyrimidinyl)-N,2,3-trimethyl-; N-(2-Chloropyrimidin-4-yl)-N-methyl-2,3-dimethyl-2H-indazol-6-amine |  | C14H14ClN5 | 詳情 | 供應商 |
| 6958-87-8 | 7H-Purin-6-amine,2-chloro-N-(2,4-dimethylphenyl)-7-methyl-; Adenine,2-chloro-7-methyl-N-2,4-xylyl- (8CI); Adenine, 2-chloro-7-methyl-N6-2,4-xylyl-(6CI); NSC 19141 |  | C14H14ClN5 | 詳情 | 供應商 | |
| 112089-14-2 | 9H-Purin-6-amine,9-[(3-chlorophenyl)methyl]-N,N-dimethyl- |  | C14H14ClN5 | 詳情 | 供應商 | |
| 115204-53-0 | 9H-Purin-6-amine,2-chloro-N,N-dimethyl-9-(phenylmethyl)- |  | C14H14ClN5 | 詳情 | 供應商 | |
| 112089-03-9 | 9H-Purin-6-amine,9-[(4-chlorophenyl)methyl]-N,N-dimethyl- |  | C14H14ClN5 | 詳情 | 供應商 |